Global mHealth Market Projected to Reach $275 Billion by 2031

The shift toward digital health is moving beyond standalone applications to encompass interconnected ecosystems. Industry analysts point to rising smartphone penetration and the global adoption of 5G as primary drivers for this transition. With 82% of individuals aged 10 and older now owning mobile devices, healthcare providers are increasingly leveraging these platforms for chronic disease management, ranging from cardiovascular health to diabetes monitoring. Major players such as Medtronic, Abbott, and ResMed are prioritizing integrated care, where patient-generated data flows directly into clinical systems.

Investment patterns reflect this trend, with significant capital flowing into AI-driven analytics and remote diagnostic platforms. Recent moves, including ResMed’s acquisition of VirtuOx and Teladoc’s expansion into virtual mental health, signal a broader consolidation of digital capabilities. As Asia Pacific emerges as a critical growth region—bolstered by initiatives like India’s Ayushman Bharat Digital Mission—the focus remains on decentralizing care. By enabling continuous health tracking outside traditional office settings, these technologies are fundamentally altering how chronic conditions are managed globally.